Acorda Therapeutics Price on December 11, 2024

ACORDelisted Stock  USD 16.20  0.40  2.41%   
If you're considering investing in Acorda Stock, it is important to understand the factors that can impact its price. As of today, the current price of Acorda Therapeutics stands at 16.20, as last reported on the 17th of December 2024, with the highest price reaching 16.60 and the lowest price hitting 15.17 during the day. We have found twenty-nine technical indicators for Acorda Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Acorda Therapeutics' Risk Adjusted Performance of 0.0793, downside deviation of 5.94, and Mean Deviation of 5.6 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Acorda Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
ACOR
Based on monthly moving average Acorda Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Acorda Therapeutics by adding Acorda Therapeutics to a well-diversified portfolio.

Related Headline

Pacira BioSciences, Headline on 11th of December 2024

DOMA Perpetual Capital Management LLC , which beneficially owns approximately 4.14 percent of the outstanding shares of Common Stock of Pacira BioSciences, Inc. , today announced that it intends to nominate four highly-qualified, independent director candidates at the Companys 2025 annual meeting of stockholders, and stated that it has hired Olshan Frome Wolosky LLP as counsel to represent it in its dealings with the Compa

Acorda Therapeutics Valuation on December 11, 2024

It is possible to determine the worth of Acorda Therapeutics on a given historical date. On December 11, 2024 Acorda was worth 16.6 at the beginning of the trading date compared to the closed value of 16.2. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Acorda Therapeutics stock. Still, in general, we apply an absolute valuation method to find Acorda Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Acorda Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Acorda Therapeutics' related companies.
 Open High Low Close Volume
12/17/2024
  16.60    16.60    15.17    16.20    0.00  
Backtest Acorda Therapeutics  |  Acorda Therapeutics History  |  Acorda Therapeutics Valuation 
Open Value
16.6
16.2
Closing Value
16.60
Upside

Acorda Therapeutics Trading Date Momentum on December 11, 2024

Acorda Therapeutics Fundamentals Correlations and Trends

By evaluating Acorda Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Acorda Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Acorda financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Acorda Therapeutics Stock history

Acorda Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Acorda is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Acorda Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Acorda Therapeutics stock prices may prove useful in developing a viable investing in Acorda Therapeutics
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. Acorda Therapeutics, Inc. was incorporated in 1995 and is headquartered in Ardsley, New York. Acorda Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 118 people.

Acorda Therapeutics Stock Technical Analysis

Acorda Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Acorda Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Acorda Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Acorda Therapeutics Period Price Range

Low
December 17, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Acorda Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Acorda Therapeutics December 17, 2024 Market Strength

Market strength indicators help investors to evaluate how Acorda Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Acorda Therapeutics shares will generate the highest return on investment. By undertsting and applying Acorda Therapeutics stock market strength indicators, traders can identify Acorda Therapeutics entry and exit signals to maximize returns

Acorda Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Acorda Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Acorda Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Acorda to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in Acorda Stock

If you are still planning to invest in Acorda Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acorda Therapeutics' history and understand the potential risks before investing.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
FinTech Suite
Use AI to screen and filter profitable investment opportunities